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The development of optimal antibody responses to T-cell-dependent antigens 
requires the participation of and interactions among at least three distinct types 
of cells in the immune system: macrophages (M~b)'; thymus-derived cells  (T 
cells);  and precursors of antibody-producing cells  (B  cells)  (1). M~b have the 
critical function of presenting antigen in a highly immunogenic form to T and B 
cells to initiate the immune response (1, 2).  Efficient physiologic interactions 
among antigen-specific murine T and B cells in the development of secondary 
IgG antibody responses appear to require that these cells share specificities 
encoded by the I  region of the H-2 complex (3, 4). Similarly, the generation of 
carrier-specific helper T cells in vitro has been reported to require that M~b and T 
cells also share specificities encoded by the I  region of the H-2 complex (5). In 
another experimental system, combinations of immune guinea pig lymphocytes 
and M~b must be syngeneic for successful development of DNA synthetic re- 
sponses to the immunizing antigen in vitro (6, 7). By contrast, genetic restric- 
tions have not been observed in interactions among murine M~b and lymphoid 
cells  (T cells and B  cell) necessary for the development of primary plaque- 
forming cell (PFC) responses in vitro; lymphoid cells develop comparable pri- 
mary PFC responses when incubated with antigen and syngeneic or allogeneic 
M~b (references 1, 2, and 8-14; and footnote 2). 
In the course of the experiments investigating the lack of genetic restrictions 
in primary PFC responses, it became obvious that one significant difference 
between our experiments and those demonstrating genetic restrictions in M~b- 
lymphocyte interactions was that the latter used immune lymphocytes. In this 
communication, we report experiments investigating the ability of syngeneic 
and allogeneic antigen-bearing M~b to stimulate secondary PFC responses by 
immune lymphoid cells in vitro. The results demonstrate that immune lymph- 
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old cells develop secondary PFC responses preferentially when stimulated by 
antigen-bearing M~b syngeneic to the M~b used to immunize the lymphoid cells 
and that these genetic restrictions are controlled by the H-2 complex. 
Materials and Methods 
Mice.  Male C57BL/6 (H-2b), C57BL/10 (H-2~), P/J (H-2P), DBA/1 (H-2q),  B10.G (H-2q), D1.LP 
(H-2b),  B10.A (H-2a), A/J (H-2a), and (C57BL/6 x  DBA/1)FI (H-2 btQ) mice were obtained from The 
Jackson  Laboratory,  Bar Harbor,  Maine,  or the Department  of Pathology Animal Facility at 
Harvard  Medical  School,  Boston,  Mass.  The  mice were  maintained  on  laboratory  chow  and 
acidified-chlorinated water and used when 2-6-mo old. 
Antigens.  Sheep erythrocytes (SRBC) (Grand Island Biological Co., Grand Island, N. Y.) were 
washed three times with Hanks' balanced salt solution (HBSS) before use as indicator cells in the 
PFC assay or as antigen in culture  (15). The synthetic linear random terpolymer of L-glutamic 
acid~°-L-alanine3°-L-tyrosinel° (GAT) (Miles Laboratories,  Inc., Miles Research Div., Kankakee, 
Ill.), mol wt approximately 45,000,  was prepared for use as antigen in culture (16), for preparing 
GAT-M~ (13,  17), and for coupling to SRBC for use as indicator cells in the PFC assay  (16),  as 
described previously. 
Culture System and Hemolytic Plaque Assay.  Spleen cells or splenic lymphoid cells, depleted 
of M~b by adherence techniques (18), at 10  ~ cells/ml in completely supplemented Eagle's minimal 
essential  medium  (MEM)  containing  10%  fetal calf serum  (lot M26302;  Reheis Chemical Co., 
Kankakee, Ill.), were incubated with graded numbers of GAT-M~b, or M~b and 10  T  SRBC, or 5 ~g 
GAT for 5 days under modified Mishell-Dutton conditions (15). Details of spocific experiments are 
in the text.  IgM and  IgG PFC  responses  to SRBC  and  IgG GAT-specific PFC  responses  were 
assayed on SRBC and GAT-SRBC indicator cells, respectively, using the slide modification of the 
Jerne hemolytic plaque assay (15,  16). Preparation of GAT-SRBC and specificity controls for the 
GAT PFC assay have been described (16). 
Preparation of GAT-Bearing  Macrophages.  Peritoneal exudate cells, as a source of M(b, were 
collected from mice injected intraporitoneally (i.p.) with 1 ml sterile 10% proteose peptone broth 
(Difco Laboratories, Detroit, Mich.) 3 days previously. This procedure routinely yielded 6-8 x  10  ~ 
cells per mouse, approximately 85% of which were morphologically M~. These cells were washed 
three times with HBSS, adjusted to 2  ×  10  ~ cells/ml in HBSS, and reacted with 100 ~g/ml GAT 
(containing 1% [12~I]GAT) at 4°C for 45-60 min (13, 17). The cells were washed three times with 50 
volumes of HBSS and adjusted to the desired density in HBSS. GAT bound to M(b was quantitated 
by counting a  portion of the cells in a  Packard Autegamma Spectrometer (Packard Instrument 
Co., Inc., Downers Grove, Ill.) and is expressed as nanograms GAT/105 or 106 cells in the tables. 
GAT-M~b were  added  in  graded  numbers  to  cultures  of 107  spleen  or  splenic  lymphoid  cells 
immediately after preparation.  In one experiment (Table I) peritoneal exudate M~b, not reacted 
with GAT, were added in graded numbers to cultures of 107 splenic lymphoid cells and 107 SRBC. 
Immunization of Mice.  Mice were immunized by i.p. injection of 3--4 ×  10  ~ GAT-M~b (bearing 
20-30  ng  GAT/10  ~ cells) or  10  ~g  GAT in  a  mixture  of magnesium-aluminum  hydroxide  gel 
(Maalox;  Wm.  H.  Rorer,  Inc.,  Fort  Washington,  Pa.)  and  pertussis  vaccine (Eli Lilly &  Co., 
Indianapolis,  Ind.)  (16). At various intervals after immunization,  spleen cells from these mice 
were assayed for secondary PFC responses to GAT in vitro. 
Results 
PFC Responses  of GAT-Primed Lymphoid Cells Stimulated by Syngeneic 
and Allogeneic M~.  The lack of genetic restrictions regulating efficient M~- 
lymphoid cell interactions in primary PFC responses will be reported in detail 
separately. 2 However, to present the data on genetic restrictions in M~b-lymph- 
old cell interactions in  secondary PFC responses in the proper context, the 
relevant data on the lack of such restrictions in the primary response should be 
summarized.  First,  syngeneic and  allogeneic M~  supported development of 
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GAT-M~b were incubated for 24 h alone before addition to lymphoid cell cultures, 
approximately 90% of the GAT initially associated with M~b was released into 
the culture medium. Since the PFC responses stimulated by these aged synge- 
neic and allogeneic GAT-M~b were comparable and not significantly less than 
responses stimulated by freshly prepared GAT-M~b, the possibility that GAT is 
transferred from allogeneic M~b  to  syngeneic M~b  contaminating the  splenic 
lymphoid cells and  that this  GAT actually stimulates the  PFC  response is 
unlikely. Third,  since allogeneic M~b may stimulate a  mixed lymphocyte re- 
sponse with resultant release of factors which stimulate antibody responses, 
DNA synthetic responses have been measured in the same cultures used to 
assess PFC responses; 7 x  104 allogeneic M~b have never stimulated significant 
DNA synthetic responses in cultures of 107 C57BL/6 lymphoid or spleen cells (E/ 
C <  1.5). Further, factors which stimulate or enhance PFC responses have not 
been demonstrated in the medium from such cultures. 
In other experiments, we observed that splenic lymphoid cells from mice 
immunized with GAT developed secondary  PFC responses to GAT preferentially 
when incubated with syngeneic GAT-M~b. To probe this phenomenon further, 
C57BL/6 mice were immunized with GAT in Maalox-pertussis and their splenic 
lymphoid cells were incubated with graded numbers of syngeneic or allogeneic 
(DBA/1 H-2  q) GAT-M~b or normal M~b and SRBC (Table I). As a control, primary 
responses to GAT by virgin C57BL/6 lymphoid cells stimulated by the same 
GAT-M~b were determined. Syngeneic and allogeneic GAT-M~b stimulated com- 
parable primary PFC  responses to GAT.  By contrast,  GAT-primed C57BL/6 
lymphoid cells preferentially developed secondary PFC responses to GAT when 
stimulated by syngeneic GAT-M~,  the  same M~b  that were involved in the 
immunization process of the lymphoid cells in vivo.  These same GAT-primed 
lymphoid cells,  however,  developed comparable primary PFC  responses  to 
SRBC  when incubated with syngeneic or allogeneic M~b, indicating that the 
restrictions observed in  secondary responses  are  antigen-specific and  not  a 
general result of immunization. 
In further experiments, C57BL/6 mice were immunized by i.p.  injection of 
syngeneic  or allogeneic (DBA!I) GAT-M~b or normal M~b as indicated in Table II. 
28 days later, spleen cells from these mice were incubated with graded numbers 
of C57BL/6 or DBA]I GAT-M~b or 5 /~g soluble GAT.  Normal DBA/1 M~b were 
added to some cultures for control purposes. Spleen cells from mice immunized 
with  C57BL/6 GAT-M~b developed secondary PFC  responses  to  GAT  when 
incubated with soluble GAT or C57BL/6 GAT-Mqb, but not when incubated with 
allogeneic DBAJ1 GAT-M~b (A). By contrast, spleen cells from mice immunized 
with DBA/1 GAT-M~b developed secondary PFC responses to GAT when incu- 
bated with  DBA/1  GAT-M~b, but  not when incubated with  soluble  GAT or 
C57BL/6 GAT-M~b (B). Spleen cells from mice immunized with beth C57BL/6 
and  DBA/1  GAT-M~b developed comparable secondary PFC  responses when 
stimulated with soluble GAT, C57BL/6, or DBA/1 GAT-M~b (C). As a control, 
unprimed C57BL/6 spleen cells developed comparable primary PFC responses 
when stimulated with soluble GAT, C57BL/6, or DBAJ1 GAT-M~b (E). 
To evaluate possible effects due to sensitization of C57BL/6 lymphocytes by 
DBA/1 M~b, C57BL/6 mice were immunized with C57BL/6 GAT-M~b plus normal 374  H-2  COMPLEX  CONTROL  OF  MACROPHAGE-LYMPHOCYTE  INTERACTIONS 
TABLE  I 
PFC Responses of GA T-Primed Lymphoid Cells Stimulated  by Syngeneic 
and Allogeneic Mob 
GAT-M~b/culture 
Day 5 IgG GAT-specific PFC/culture 
107 virgin lymphoid 
cells -  C57BL/6 (H-2  b) 
107 GAT-primed lymph- 
oid cells* -  C57BL/6 
(H-2  ~  ) 
C57BL/6  DBA/1  C57BL/6  DBA/1 
M~b$ (H-2  b)  Mdp$  (H-2  q)  M~b* (H-2  b)  Mdp* (H-2  q) 
7  ×  104  2,950  2,445  3,980  1,260 
3.5  ×  104  530  1,195  3,310  710 
1  ×  104  <10  105  1,130  105 
No M¢ -5  ~gGAT  <10  205 
Mob/culture +  107 SRBC 
Day 5 anti-SRBC PFC/culture 
107 GAT-primed lymphoid cells* -  C57BL/6 (H-2  b) 
C57BL/6 M~§  DBA/1 M~§ 
IgM  IgG  IgM  IgG 
7  x  104  1,535  490  1,340  490 
3.5  ×  104  1,095  245  675  150 
1  × i04  270  60  405  ii0 
No M~  +  107 SRBC  195  85  -  - 
* Lymphoid  cells were prepared  from spleen cell suspensions from C57BL/6  mine 
immunized 53 days previously by i.p. injection of 10 ~g GAT in Maalox-pertussis. 
At culture initiation, these cells had 25 IgG GAT-specific PFC per 107 cells. 
C57BL/6 M~b, 1.20 ng GAT/10  ~ cells; DBA/1 M~b, 1.25 ng GAT/105 cells. 
§ Normal, non-GAT-bearing Mob. 
DBAJ1 M~b  (D). Further,  cultures with both  C57BL/6 GAT-M~  and  normal 
DBA/1  M~b  provide critical control information.  Normal DBA/1  M~b  had no 
significant effect on responses stimulated by C57BL/6 GAT-M~b in cultures of 
spleen cells from mice immunized with C57BL/6 GAT-M~b (A), C57BL/6 GAT- 
M~b and DBA/1 GAT-M~b (C), C57BL/6 GAT-M~b and normal DBA/1 M~b (D), or 
unprimed spleen cells (E). These observations indicated that DBAJ1 M~b did not 
stimulate a  suppressive effect on secondary responses of appropriately immu- 
nized spleen cells to C57BL/6 GAT-M~b. Further, DBA/1 M~b added to cultures of 
spleen cells from mice immunized with DBA/1 GAT-M~b did not enhance the 
responses in cultures containing C57BL/6 GAT-M~b (B). This suggested that 
allogeneic M~  did  not  stimulate  a  nonspecific enhancing effect and,  more 
importantly, that any transfer of GAT from C57BL/6 to DBA/1 M~b was insuffi- 
cient to stimulate a secondary PFC response to GAT. 
Comparable results have been obtained when P/J (H-2  p) or BALB/c (H-2  d) 
M~b were substituted for DBA/1 M~b throughout the experiment. Further, signif- 
icant DNA synthetic responses (E/C  <  1.5) were not detected in cultures of 
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TABLE  II 
Secondary PFC Responses to GAT Stimulated by Syngeneic and Allogeneic M~ in 
Cultures of Spleen Cells Primed with GAT-Mdp 
GAT-M4~ used to prime ~pleen 
cells*  GAT-M~b/culture 
Day 5 IgG GAT-specific PFC/culture 
107 spleen cells -  C57BL/6 (H-2  b) 
C57BL/6  DBA/1 
M~b$ (H-2')  M~b* (H-2  q)  5/~g GAT 
A  C57BL/6 (H-2  ~) 
B  DBA/1 (H-2  q) 
C  C57BL/6  +  DBA/1 
D  C57BL/6  +  normal DBA/1 
E  None (unprimed spleen cells) 
5  x  104  425  <10 
2.5  ×  104  265  <10  680 
2.5  ×  104§  420  - 
5  ×  104  20  1,020 
2.5  x  10'  30  760  <10 
2.5  ×  104§  30  - 
5  ×  104  1,510  850 
2.5  ×  104  1,040  910  1,270 
2.5  ×  104§  1,020  - 
5  x  104  355  <10 
2.5  x  104  840  <10  1,020 
2.5  x  104§  350  - 
5  x  104  1,110  870 
2.5  x  104  410  520  1,255 
2.5  x  104§  1,520  - 
* C57BL/6 mice  were immunized 28  days  previously  by  i.p.  injection  of  4 x i06  of  the  indicated  M~b. 
C57BL/6 M~b, 33.5  ng GAT/10  ~ cells;  DBA/1 Me, 27.0  ng GAT/106 cells.  At culture initiation, 
these spleen cells  had <25 IgG GAT-specific PFC per 107  cells. 
C57BL/6 M~b, 2.78  ng GAT/105 cells;  DBA/1 M~b,  3.15  ng GAT/105 cells. 
§ 2.5 ×  104 non-GAT-bearing DBA/1 M~b were added to cultures containing 2.5 x 104 C57BL/6 
GAT-M&. 
neic  M~b.  These genetic  restrictions  regulating  efficient  M~b-lymphoid cell  inter- 
actions  in  secondary  antibody responses cannot  be  demonstrated before  2  wk and 
disappear gradually 8 wk after  a single  immunization with GAT-M~b. 
Localization  of Genetic Restrictions Regulating Macrophage-Lymphoid  Cell 
Interactions  in  Secondary  PFC Responses  to  the  H-2  Complex.  The  next 
experiments were  designed to  determine if the  restrictions regulating  M~b- 
lymphoid cell interactions in secondary PFC responses were controlled by the H- 
2  gene complex. C57BL/6 mice were immunized with syngeneic or allogeneic 
(DBA/1)  GAT-M~b and 24 days later spleen cells from these mice were stimu- 
lated with GAT-M~b from the five strains of mice indicated in Table III. Primary 
PFC responses to GAT by virgin spleen cells demonstrated that all the GAT-M~b 
were capable of stimulating antibody responses  (A).  Spleen cells from mice 
immunized with C57BL/6 GAT-M~ developed secondary PFC responses to GAT 
preferentially when stimulated with C57BL/6 (H-2b),  D1.LP (H-2  b on DBA/1 
background), and (C57BL/6  ×  DBA/1)F1 (H-2  o/q) GAT-M~b (B). Further, spleen 
cells from mice immunized with allogeneic DBA/1 GAT-M~b developed second- 
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TABLe.  III 
Secondary PFC Responses to GAT by C57BL/6 Spleen Cells Primed with GAT-M$ 
Depend on the H-2 Haplotype of the Stimulating Macrophages 
Day 5 IgG GAT-specific PFC/culture 
107 spleen cells -  C57BL/6 (H-2  ~) 
GAT-M¢b used to prime  GAT-M~b/  (B6  × 
spleen ceils*  culture  C57BL/6  DBA/1  B10.G  D1.LP  D1)F~ 
M~b~  M~b*  M4~  M~$  M~$ 
(H-2  b)  (H-2 q)  (H-2  q)  (H-2  b)  (H.2btq) 
A  None (unprimed spleen  7  ×  104  740  800  940  500  330 
cells)  5  ×  104  980  850  760  500  1,050 
2.5  ×  104  970  630  710  380  240 
None  <10  .... 
B  C57BL/6 (H-2  b)  7  ×  104  210  <10  20  330  570 
5  ×  104  350  <10  <10  350  230 
2.5  ×  104  40  <10  50  240  200 
None  40  -  -  -  " 
C  DBA/1 (H-2  q)  7  ×  104  30  210  480  40  430 
5  ×  104  20  150  260  40  310 
2.5  ×  104  90  220  320  40  <10 
None  30  .... 
* C57BL/6 mice were immunized  24 days previously by i.p. injection of  3 ×  106 of the indicated M~b. 
C57BL/6 M~b, 33.5 ng/10  ~ cells; DBA/1 M~b, 25.0 ng/10  ~ cells. At culture initiation these spleen 
cells had <30 IgG GAT-specific PFC per 10  ~ cells. 
$ C57BL/6 M~b, 2.25 ng GAT/I(Y  ~ cells; DBA/1 M~, 1.75 ng GAT/105 cells; B10.G M~b, 2.00 ng GAT/ 
10  "~ cells; D1.LP M~b, 2.00 ng GAT/10  '~ cells; (C57BL/6 × DBA/1)F~, (B6 × D1)F~ M<b, 1.85 ng GAT/ 
10  '~ cells. 
(H-2  q on C57BL/10 background), and (C57BL/6  ×  DBA/1)F1  (H-2  bIQ) GAT-M~b 
(C). 
Thus,  secondary PFC responses to GAT are  elicited preferentially by M~b 
syngeneic or semisyngeneic at the H-2 complex with the M~ which presented 
GAT to the lymphocytes during the in vivo immunization process. The experi- 
ment in Table IV demonstrates the involvement of the H-2  complex in this 
phenomenon again, using spleen cells from B10.A (H-2  a) mice immunized with 
B10.A GAT-M~b. These spleen cells developed secondary PFC responses when 
stimulated with B10.A or A/J  (H-2 ~) GAT-M~b, but not when stimulated with 
allogeneic B10 (H-2  b) or P/J (H-2  p) GAT-M~b. It should be noted in both Tables 
III and IV that GAT-M~b from strains with the same genetic background and 
differing only at the H-2 complex from Mob used in the immunization process, 
failed to stimulate significant secondary PFC responses to GAT in vitro. 
Discussion 
These experiments illustrate some major points concerning genetic restric- 
tions regulating efficient M~b-lymphoid cell interactions in the development of 
primary and secondary antibody responses in vitro. First, in primary antibody 
responses, no genetic restrictions have been demonstrated; syngeneic and allo- 
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TABLE  IV 
Secondary PFC Responses to GA T by B10.A Spleen Cells Primed with GA T-Md~ Depend 
on the H-2 Haplotype of Stimulating Macrophages 
GAT-Mcb used to  prime  GAT-M4d 
spleen  cells*  culture 
Day 5 IgG GAT-specific PFC/culture 
107 spleen cells-B10.A (H-2 ~) 
B10.A Me*  A/J M~b$  B10 Mobs  P/J M~b$ 
(H-2  a)  (H-2  ~)  (H-2  b)  (H-2  p) 
None (unprimed spleen  7  ×  104  590  450  580  470 
cells)  5  ×  104  1,110  400  450  340 
None  <10  -  -  - 
B10.A (H-2 ~)  7  ×  104  760  670  <10  <10 
5  ×  104  660  780  60  60 
None  70  -  -  - 
* B10.A mice were immunized 15 days previously by i.p. injection of  3 × 106 B10.A M~b bearing 17.0 
ng GAT/106 cells. At culture initiation, these cells had 30 IgG GAT-specific PFC per 10  ~ cells. 
B10.A M~b, 2.00 ng GAT/105 cells; A/J M¢b, 2.50 ng GAT/105 cells; B10 M~b, 2.00 ng GAT/105 cells; 
P/J M~b, 1.80 ng GAT/105 cells. 
ary  antibody response,  genetic restrictions are  operative;  immunized spleen 
cells develop antibody responses preferentially when stimulated with antigen- 
bearing  M~b  syngeneic with  the  M~b  which presented antigen to  the  virgin 
lymphocytes during the  immunization process in  vivo.  Third,  these genetic 
restrictions are  controlled by the H-2  complex. Fourth, they can be  demon- 
strated only during a limited period, from 2 to 8 wk, aiter a single immunization 
with limiting quantities of antigen on M~b. Fifth, these restrictions in secondary 
antibody responses are antigen specific; responses of the same primed lymphoid 
cells to another antigen do not exhibit genetic restrictions. Sixth, these genetic 
restrictions  appear  to  operate  at  the  level  of the  immune T  cell,  although 
restrictions at the level of the B cell have not yet been rigorously excluded (19). 
The  antigen used in  these  experiments was  the  synthetic linear  random 
terpolymer of GAT. Antibody responses to GAT are under H-2-1inked, immune 
response gene control; mice of the H-2 a'b'dJz'k'r'u'v  haplotypes are "responders" 
(20); spleen cells from these mice develop IgG GAT-specific PFC responses when 
stimulated with soluble GAT or GAT-M& in Mishell-Dutton cultures. Spleen 
cells from mice of the H-2 n'p'q'" haplotypes fail  to respond to  GAT and  are 
"nonresponders" (16, 20). M~b and helper T cells are required for development of 
antibody responses to  GAT by responder B  cells in  vitro,  and the defect in 
nonresponder mice  is  not in  M~b  (13). M~b  from  peptone-induced peritoneal 
exudates of responder and nonresponder mice bind approximately equal quanti- 
ties of GAT,  and these M~b  bearing nanogram quantities of GAT stimulate 
comparable PFC responses by responder lymphoid cells (13, 14, 17). 
The genetic restrictions regulating efficient M~b-lymphoid cell interactions in 
secondary antibody responses have been investigated, to date, only with GAT. 
However,  these restrictions have been demonstrated with three types of re- 
sponder spleen or lymphoid cells: C57BL/6 (H-2b),  BALB/c (H-2d),  and B10.A 
(H-2a);  and with M~b from several murine strains, which are both responders 
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encoded by the H-2 complex with the responder lymphoid or spleen cells. Thus, 
the observations appear to reflect a general phenomenon  in secondary responses 
to  this  antigen  and  are  not  restricted  to  limited combinations of M~b  and 
lymphoid cells. 
It should be pointed out, however, that the observed genetic restrictions in 
secondary antibody responses are the only criteria of successful in vivo immuni- 
zation  in  these  experiments available  at  this  time.  IgG  GAT-specific PFC 
responses in spleens of mice immunized with GAT-M~ are insignificant com- 
pared to those elicited by 10 tzg of GAT. The secondary PFC responses to GAT in 
vitro  have  the  same  kinetics of development and  are  of the  same  general 
magnitude as primary PFC responses. The possibility that immunization with 
GAT-M~b may lead to a significant shift in the Ig class of the PFC from IgG1 to 
IgG2 in the secondary response is currently under investigation. 
Another observation which deserves comment at this juncture is that spleen 
cells from mice immunized with allogeneic GAT-M~b, although developing sec- 
ondary PFC responses when stimulated with the same allogeneic GAT-M~, do 
not develop significant primary PFC responses when stimulated with soluble 
GAT or syngeneic GAT-M~.  In part,  this phenomenon may be related to the 
problem of criteria of immunization discussed above. Since these spleen cells do 
respond to the GAT-M~ used for immunization, it is clear that the immune 
apparatus is intact, i.e., functional specific T cells and B cells are present. Since 
other studies have indicated that the genetic restrictions operate at the level of 
the T cell and not the B cell (19), this observation implies that virgin T cells were 
either not present in  spleens of mice immunized with GAT-M~,  or that,  if 
present, their function was either pre-empted or suppressed by the primed T 
cells. At this time, we have no data to permit a choice among these possibilities. 
The observations that secondary antibody responses by immunized lymphoid 
cells develop preferentially with M~b syngeneic with those used for immuniza- 
tion and that these genetic restrictions appear to operate at the level of the 
immune T  cells,  provide an  explanation for the genetic restrictions in  M~b- 
lymphocyte interactions observed in DNA synthetic responses to antigen by 
guinea pig cells (6, 7). The lymphocytes in these experiments were from animals 
immunized in the presence of syngeneic M~. The fact that these lymphocytes 
develop DNA synthetic responses preferentially in the presence of syngeneic M~b 
is, therefore, entirely consistent with the present findings. More recent observa- 
tions involving transfer of delayed hypersensitivity in mice indicate that sensi- 
tized T cells elicit these responses only when transferred to hosts whose M~b are 
syngeneic at the I  region of the H-2  complex with those present during the 
sensitization of the T cells (21, 22). These observations emphasize the critical 
nature of the M4~ membrane-antigen complex in the sensitization of T cells and 
in eliciting subsequent responses by immune T cells. 
The present findings appear to be in conflict with recent observations that 
helper T cells develop in vitro only in the presence of M~ sharing specificities 
encoded by the I region of the H-2 complex with the T cells (5). However, in the 
assay of helper T-cell activity, M~b syngeneic with the T cells, but not syngeneic 
with M~b used to generate the helper T cells, have been employed. On the basis 
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used to generate helper T cells were used in the assay, the helper T cells would 
function preferentially with these M~b. If the genetic restrictions involved in the 
generation of helper T cells are indeed explained on the basis of the secondary 
response restrictions demonstrated in the present experiments, both phenomena 
should be  attributable  to/-region gene products expressed on M~b. Studies 
mapping the genetic restrictions in the present system are in progress. 
The observations that specifically sensitized T  cells respond preferentially 
when confronted with the same M~-antigen complex used for immunization 
have considerable implications for the understanding of fundamental mecha- 
nisms in immune responses to T-cell-dependent antigens. First, these observa- 
tions provide evidence for a more actively specific role for M~b in immunizing T 
cells and eliciting subsequent specific responses by T cells than just presentation 
of antigen in a highly immunogenic form. Moreover, a role for antigens encoded 
by the H-2  complex in  this process is  demonstrated. Thus,  immune T  cells 
appear to recognize and respond to specific antigen selectively or preferentially 
when confronted with that antigen in the context of M~b-membrane molecules 
encoded by the H-2 complex. Whether M~b-membrane molecules are modified in 
some way when presenting antigen, i.e.  "altered-self concept," or whether T 
cells recognize antigen only in  the  context of specific, unaltered membrane 
molecules, i.e. "linked-recognition concept," is not known at this time (23). 
Nevertheless, the M~b membrane-antigen complex involved in these phenom- 
ena may be analogous to the hapten-carrier complex involved in stimulating B 
cells,  i.e.,  M~b  membrane  molecules may function as  a  "carrier"  for  T-cell 
antigen recognition. Since the genetic restrictions regulating Mob-lymphoid cell 
interactions in secondary antibody responses are determined by the H-2  com- 
plex, these phenomena may represent an expanded capacity of T cells to recog- 
nize antigens encoded by theI region oftheH-2 complex, analogous to the mixed 
lymphocyte reaction. Recent observations indicate that T cells participating in 
the mixed lymphocyte response can also participate in responses to nonhisto- 
compatibility antigens (24). From an evolutionary point of view, recognition of 
histocompatibility antigens is a primitive mechanism. It is possible that during 
evolution T cells have expanded the library of antigens which they recognize 
and respond to by "seeing" these antigens displayed on Me membranes in the 
context of histocompatibility antigens. This ability to recognize new antigens 
would provide obvious survival advantages for the species. 
Summary 
The ability of antigen-bearing syngeneic and allogeneic peptone-induced peri- 
toneal exudate macrophages to support development of primary and secondary 
antibody responses by murine lymphoid or spleen cells in vitro has been investi- 
gated. The antigen used was the terpolymer of L-glutamic acid6°-L-alanine30-L  - 
tyrosine  ~°  (GAT).  Syngeneic and  allogeneic macrophages supported develop- 
ment of comparable primary antibody responses to GAT, indicating that genetic 
restrictions do not limit efficient macrophage-lymphocyte interactions in pri- 
mary responses.  By contrast,  immunized spleen or lymphoid cells developed 
secondary antibody responses preferentially when stimulated in vitro with GAT 
on macrophages syngeneic to the macrophages used to present GAT during in 380  H-2  COMPLEX  CONTROL  OF  MACROPHAGE-LYMPHOCYTE  INTERACTIONS 
vivo immunization. Thus,  genetic restrictions regulate efficient macrophage- 
lymphocyte interactions in  secondary antibody responses.  These restrictions 
have  been  demonstrated from  2  to  8  wk  after a  single  immunization  with 
limiting quantities of GAT and are controlled by the H-2  gene complex. The 
implications  that  immune  lymphocytes selectively recognize and  respond  to 
antigen presented in the context of the macrophage membrane-antigen complex 
which sensitized the lymphocytes initially are considered. 
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